CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
1.090
-0.010 (-0.91%)
At close: Dec 20, 2024, 4:00 PM
1.067
-0.023 (-2.11%)
After-hours: Dec 20, 2024, 6:50 PM EST
CytomX Therapeutics Employees
As of December 31, 2023, CytomX Therapeutics had 122 total employees, including 120 full-time and 2 part-time employees. The number of employees increased by 4 or 3.39% compared to the previous year.
Employees
122
Change (1Y)
4
Growth (1Y)
3.39%
Revenue / Employee
$1,037,844
Profits / Employee
$113,361
Market Cap
85.30M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Cibus | 183 |
Exagen | 179 |
LENSAR | 130 |
Skye Bioscience | 11 |
Coya Therapeutics | 8 |
Anixa Biosciences | 5 |
Context Therapeutics | 5 |
OS Therapies | 4 |
CTMX News
- 25 days ago - CytomX Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference - GlobeNewsWire
- 6 weeks ago - CytomX Therapeutics, Inc. (CTMX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - CytomX Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - CytomX Therapeutics Announces First Patient Dosed with CX-801, a Dually-Masked Interferon-Alpha 2b PROBODY®, in a Phase 1 Study in Patients with Solid Tumors - GlobeNewsWire
- 4 months ago - CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 6 months ago - CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference - GlobeNewsWire
- 6 months ago - CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer - GlobeNewsWire
- 7 months ago - CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire